Bank of America’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.42K Sell
1,469
-15,694
-91% -$25.9K ﹤0.01% 6370
2025
Q1
$27.1K Buy
17,163
+15,672
+1,051% +$24.8K ﹤0.01% 5864
2024
Q4
$5K Sell
1,491
-787
-35% -$2.64K ﹤0.01% 6174
2024
Q3
$4.28K Sell
2,278
-28
-1% -$53 ﹤0.01% 6107
2024
Q2
$4.54K Buy
2,306
+119
+5% +$234 ﹤0.01% 6140
2024
Q1
$6.71K Sell
2,187
-598
-21% -$1.84K ﹤0.01% 6063
2023
Q4
$6.49K Sell
2,785
-638
-19% -$1.49K ﹤0.01% 6010
2023
Q3
$13.8K Sell
3,423
-777
-19% -$3.14K ﹤0.01% 5876
2023
Q2
$17.2K Sell
4,200
-550
-12% -$2.26K ﹤0.01% 5867
2023
Q1
$14.6K Sell
4,750
-184
-4% -$567 ﹤0.01% 6026
2022
Q4
$13.3K Buy
4,934
+7
+0.1% +$19 ﹤0.01% 6045
2022
Q3
$20K Buy
4,927
+70
+1% +$284 ﹤0.01% 6177
2022
Q2
$34K Sell
4,857
-117
-2% -$819 ﹤0.01% 6197
2022
Q1
$58K Sell
4,974
-1,838
-27% -$21.4K ﹤0.01% 6325
2021
Q4
$125K Buy
6,812
+686
+11% +$12.6K ﹤0.01% 5947
2021
Q3
$154K Sell
6,126
-2,164
-26% -$54.4K ﹤0.01% 5623
2021
Q2
$524K Buy
8,290
+1,615
+24% +$102K ﹤0.01% 4678
2021
Q1
$822K Buy
6,675
+339
+5% +$41.7K ﹤0.01% 4424
2020
Q4
$721K Sell
6,336
-1,289
-17% -$147K ﹤0.01% 4095
2020
Q3
$912K Sell
7,625
-287
-4% -$34.3K ﹤0.01% 3769
2020
Q2
$986K Buy
7,912
+6,327
+399% +$788K ﹤0.01% 3670
2020
Q1
$306K Buy
1,585
+511
+48% +$98.7K ﹤0.01% 4302
2019
Q4
$358K Buy
1,074
+23
+2% +$7.67K ﹤0.01% 4501
2019
Q3
$339K Sell
1,051
-25
-2% -$8.06K ﹤0.01% 4582
2019
Q2
$464K Buy
1,076
+535
+99% +$231K ﹤0.01% 4409
2019
Q1
$306K Sell
541
-45
-8% -$25.5K ﹤0.01% 4601
2018
Q4
$173K Buy
586
+48
+9% +$14.2K ﹤0.01% 4896
2018
Q3
$381K Buy
538
+496
+1,181% +$351K ﹤0.01% 4449
2018
Q2
$25K Buy
42
+35
+500% +$20.8K ﹤0.01% 5696
2018
Q1
$18K Buy
+7
New +$18K ﹤0.01% 5665